assessing the role of mobile solutions in clinical workflow and access to clinical information in...

21
Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration at BCCA May 27 th , 2013 Jonn Wu, MD FRCPC John Waldron, CPHIMS eHealth 2013 Ottawa, Ontario

Upload: susanna-mcbride

Post on 12-Jan-2016

232 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

Assessing the Role of Mobile Solutions in Clinical Workflow and Access to

Clinical Information in Oncology

A Catalyst for Innovation and Collaboration at BCCA

May 27th, 2013

Jonn Wu, MD FRCPCJohn Waldron, CPHIMS

eHealth 2013

Ottawa, Ontario

Page 2: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

Faculty/Presenter Disclosure• Faculty:

Dr. Jonn Wu, BC Cancer Agency

John Waldron, Provincial Health Services Authority

• Nothing to disclose

Page 3: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

3

Outline

The Impetus for ChangePhase I – Mobility ProjectDr. Jonn Wu

Evolving and Evaluating MobilePhase II – Acting on Key FindingsJohn Waldron

Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology

A Catalyst for Innovation and Collaboration at BCCA

Page 4: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

4

Outline – Dr. Jonn Wu

The Impetus for Change

Phase I – Mobility Project• Paper Charts, Desktops• Clinical Requirements, Proposed Solution• Study Methodology• Results

Page 5: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

5

CAIS: Cancer Agency Information System

Paper Chart vs CAIS

Page 6: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

6

CAIS, Desktops: Office Area

Page 7: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

7

Solution: CAIS via Citrix, iPad

Small, Mobile

Easy to Use

Secure

ExistingInfrastructure

ExistingSoftware

Tablet

iOS, CAIS

Citrix, read-only, MDM

Campus-wideWifi

Citrix,CAIS

Page 8: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

8

iPad Pilot Project – Phase I

A pessimist sees the difficulty in every opportunity;an optimist sees the opportunity in every difficulty.

Sir Winston Churchill

Objectives: To address the clinical need for

1.improved computer and EHR access. 2.access to up to date patient records.3.mobile tools for use in patient rooms.

Page 9: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

9

Phase I - Methodology

34 Radiation OncologistsPre-Usage Survey: 16 Questions

3 Months(April 1 – July 1, 2012)

Post-Usage Survey: 36 Questions Interview

Page 10: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

10

Phase I – Results – Pre-SurveyRadiation Oncologists - Relatively Tech Savvy•86% - use mobile device daily•78% - use mobile device in clinic

Enthusiastic, Clinician Driven•67% - will enhance clinical workflow•91% - looking forward to adding mobile device to workflow

Page 11: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

11

Phase I – Results – Post-Survey

30 Responses, 88% Response Rate

The Good:•70% - easy to carry around•63% - positive impact on workflow•76% - more current than paper chart• 96% - accessed emails•60% - installed additional medical apps

The Bad:•50% - satisfied with screen size•55% - sufficient to review electronic records•55% - text too small• 50% - appropriate screen size

Page 12: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

12

Phase I – Summary

Clinician Driven Initiative

Positive Impact to Clinical Workflow•83% - positive experience (3% negative)•73% - useful in clinical practice•Addressed: Space and access concerns

Limitations Phase II•Usability

Page 13: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

13

Phase II: Evolving and Evaluating Mobile

1. Provide access to relevant clinical information Action: Source data from the 2 primary EHRs, Rx

2. Address usability Action: Use iPad with native iOS app

3. Address privacy and security requirements Action: MDM server, PIA, STRA

4. Evaluate utility of mobile solution in variety of clinical settings and workflows Action: Oncology, acute, ambulatory

Complete research-based evaluation

Acting on Key Findings

Page 14: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

14

Phase II: Baseline Results - BCCA

Pain Points Identified:BCCA clinicians lacked access to EHR systems in: (Ie. Exam rooms, RT planning areas, conferences)Some areas don’t have access to even the paper chart. (Fairmont outpatient clinics) The mobile workforce tethered to fixed workstation

Key Observation:BCCA clinicians have adopted mobile technology.

Page 15: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

15

Phase II: Baseline

Key Observation:Desire to use mobile for patient care activities.

Page 16: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

16

Phase II: Post Implementation Satisfaction

Key Observation:Device (iPad) and application were very well received at BCCA.

Page 17: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

17

Phase II: Access to Clinical Information

85% reported reduction in their need for the paper chart 62% reported reduction in their need for desktop PCs

Key Observation:Solution used when no workstation is available.

Page 18: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

18

Phase II: Solution UsageKey Observation:Most of the respondents reported using solution daily with an average of 9.2 and 8 (times/day) respectively.

Page 19: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

19

Phase II: Service Quality

Key Observation:•Most participants (90%) agree that there were sufficient technical support and training resources, despite the fact no formal training was provided.

Page 20: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

20

Phase II: Conclusions

Critical Success Factors: Clinician driven initiativeIMITS act as an enablerMulti-disciplinary teams and great teamwork

Provider use of mobile technology and modern applications has a positive impact on clinical workflow and patient care

Access to more data from one place is desirable: medical imaging, physician’s action lists, Varian

Next Step: Procurement

Page 21: Assessing the Role of Mobile Solutions in Clinical Workflow and Access to Clinical Information in Oncology A Catalyst for Innovation and Collaboration

21

AcknowledgementsProject Team•Executive sponsors: K. Karmali, Dr. I. Olivotto, B. Rivelis•Team Members: Dr. M. Khan, J. Barnett, J. French•Project Manager, IMITS: S. Hood•Clinical Systems Lead: M. Chow•CAIS/EVE Developer: C. Leckie•Cerner Resources: D. Tourrond•Mobile app vendor: VitalHub•Researcher (UVic): S. Slager, S. Melhem, O. Shabestari•Infrastructure Support: A. Kahnamelli•CIVIC – Innovation Centre: P. RamirezParticipants•Physician champions•50 Radiation and Medical Oncologists•Super users across 6 BCCA sites•40 Users at C&W (pending)